Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Segami is a private healthcare software company focused on vendor-neutral nuclear medicine and molecular imaging workflow solutions. Its flagship Oasis and Oasis V3 platforms are used to process, review, quantify, and interpret diagnostic images across SPECT, PET, CT, MR, and related multimodality environments in cardiology, oncology, neurology, and general nuclear medicine. The company also offers specialized applications such as QuickViewer for rapid multimodality image display, CerQuant for brain quantification, and DopaQuant for DaTscan analysis. Segami positions itself as an interoperable imaging software provider that helps nuclear medicine departments improve workflow efficiency, compatibility across scanner vendors, and diagnostic confidence. The business appears to be commercially focused rather than drug-development oriented.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Segami.